Bariatric surgery for type 2 diabetes: To whom and when?

Minerva Endocrinologica

Volumn 38, Issue 1, 2013, Pages 47-58

  Samaras, K ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Bariatric surgery; Diabetes mellitus; Metabolism; Obesity

Indexed keywords

GLUCOSE; INSULIN;

BARIATRIC SURGERY; BODY MASS; CASE CONTROL STUDY; DIET RESTRICTION; FOLLOW UP; GLYCEMIC CONTROL; HEART FUNCTION; HUMAN; LIPID METABOLISM; MEDLINE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OBSERVATIONAL STUDY; PROCESS OPTIMIZATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROUX EN Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; STOMACH BYPASS;

EID: 84876584601     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. International Diabetes Federation. The IDF Diabetes Atlas. Fifth Edition. The global burden. 2012. [cited 2012 November 23]. Available at: http://www.idf.org/diabetesatlas/5e/the-global-burden
2. Kramer H, Cao G, Dugas L, Luke A, Cooper R, Durazo-Arvizu R. Increasing BMI and waist circumference and prevalence of obesity among adults with type 2 diabetes: the National Health and Nutrition Examination Surveys. J Diabetes Complications 2010;24:368-74.
3. Dixon JB, Chuang LM, Chong K, Chen SC, Lambert GW, Straznicky NE et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2012 [Epub ahead of print].
4. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011;146:143-8.
5. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-85.
6. Pinheiro JS, Schiavon CA, Pereira PB, Correa JL, Noujaim P, Cohen R. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis 2008;4:521-5.
7. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366.1567-76.
8. Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, Pendleton RC et al. Health benefits of gastric bypass surgery after 6 years. JAMA 2012;308:1122-31.
9. Adams TD, Pendleton RC, Strong MB, Kolotkin RL, Walker JM, Litwin SE et al. Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity 2010;18:121-30.
10. Hofso D, Jenssen T, Hager H, Roislien J, Hjelmesaeth J. Fasting plasma glucose in the screening for type 2 diabetes in morbidly obese subjects. Obesity Surgery 2010;20:302-711.
11. Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 2011;34:561-7.
12. Leslie DB, Dorman RB, Serrot FJ, Swan TW, Kellogg TA, Torres-Villalobos G et al. Efficacy of the Rouxen-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus. Obesity Surgery 2012;22:367-74.
13. Pontiroli AE, Folli F, Paganelli M, Micheletto G, Pizzocri P, Vedani P et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 2005;28:2703-9. (Pubitemid 43951163)
14. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Annals of Surgery 2011;253:699-703.
15. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93. (Pubitemid 39665322)
16. 2. Obesity Surgery 2011;21:889-95.
17. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Lee YC. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. Journal of Gastrointestinal Surgery 2012;16:45-51; discussion -2.
18. 2. J Gastrointest Surg 2008;12:945-52.
19. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-56 e5.
20. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-23. (Pubitemid 351159368)
21. Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010;33:1438-42.
22. Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obesity Surgery 2008;18:294-9.
23. Centre for Disease Control and Prevention. National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2007. In: US Department of Health and Human Services. Atlanta, GA: CDC; 2008.
24. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753-61. (Pubitemid 47295642)
25. MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997;1:213-20. (Pubitemid 127432762)
26. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085-90. (Pubitemid 35192814)
27. Samaras K, Viardot A, Lee PN, Jenkins A, Botelho NK, Bakopanos A et al. Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: The role of immune cell activation and insulin resistance. Diabetes and Vascular Disease Research 2012 [Epub ahead of print].
28. Barinas-Mitchell E, Kuller LH, Sutton-Tyrrell K, Hegazi R, Harper P, Mancino J et al. Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes. Diabetes Care 2006;29:2218-22. (Pubitemid 44899855)
29. Ikonomidis I, Mazarakis A, Papadopoulos C, Patsouras N, Kalfarentzos F, Lekakis J et al. Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens 2007;25:439-47. (Pubitemid 46071943)
30. Shargorodsky M, Fleed A, Boaz M, Gavish D, Zimlichman R. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity. Int J Obes 2006;30:1632-8. (Pubitemid 44657837)
31. Rider OJ, Francis JM, Ali MK, Petersen SE, Robinson M, Robson MD et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 2009;54:718-26.
32. Hanusch-Enserer U, Zorn G, Wojta J, Kopp CW, Prager R, Koenig W et al. Non-conventional markers of atherosclerosis before and after gastric banding surgery. Eur Heart J 2009;30:1516-24.
33. Konukoglu D, Uzun H, Firtina S, Cigdem Arica P, Kocael A, Taskin M. Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obesity Surgery 2007;17:672-8. (Pubitemid 46950641)
34. Viardot A, Lord RV, Samaras K. The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab 2010;95:2845-50.
35. Myers VH, McVay MA, Adams CE, Barbera BL, Brashear MM, Johnson WD et al. Actual medical and pharmacy costs for bariatric surgery: 6-year follow-up. Southern Medical Journal 2012;105:530-7.
36. Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care 2009;32:567-74.
37. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
38. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50. (Pubitemid 32378388)
39. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-61. (Pubitemid 38196725)
40. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-86.
41. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93:4774-9.
42. Lynch J, Belgaumkar A. Bariatric surgery is effective and safe in patients over 55: a systematic review and meta-analysis. Obesity Surgery 2012;22:1507-16.
43. Ramirez A, Roy M, Hidalgo JE, Szomstein S, Rosenthal RJ. Outcomes of bariatric surgery in patients >70 years old. Surg Obes Relat Dis 2012;8:458-62.
44. Dixon JB, Zimmet P, Alberti KG, Mbanya JC, Rubino F. Bariatric surgery for diabetes: the International Diabetes Federation takes a position. J Diabetes 2011;3:261-4.
45. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:1577-96.
46. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-79.
47. Endocrine Society. Evaluating the benefits of treating type 2 diabetes with bariatric surgery. An Endocrine Society Statement to providers on study findings related to medical versus surgical treatment of obese patients with type 2 diabetes, [cited 2012 November 23]. Available at: http://www.endo- society.org/advocacy/policy/index.cfm
48. Hofso D, Nordstrand N.Johnson LK, Karlsen TI, Hager H, Jenssen T et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. European journal of endocrinology/European Federation of Endocrine Societies 2010;163:735-45.
49. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care 2012;35(Suppl 1).S27-8.
50. Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012;35:1420-8.